free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

News of Note—Seqirus, Fujifilm and more

fiercepharmaAugust 17, 2017

Tag: Seqirus , Fujifilm , Intellia

> Seqirus executives expect to break even this year and report that the flu vaccine company is on track to profitability. 

> Fujifilm Diosynth and Texas A&M University are collaborating as a Center for Innovation in Advanced Development and Manufacturing. 

> Flu vaccines were 48% effective overall last year, according to a study published in The New England Journal of Medicine. 

> Former GlaxoSmithKline vaccine head Moncef Slaoui resigned from Intellia's board.

> Vaxess, a preclinical vaccine biotech, picked up former Sanofi Pasteur head Wayne Pisano for its advisory board.

Previous:Commercial Application Segment to Dominate Global Small Molecule API Market

Next:LifeArc, Metrion to support neuroscience molecule drug discovery programme

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service